Home

Articles from Bioptimus

Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology
Bioptimus, the pioneering AI foundation model company, announced today that it has reached a significant funding milestone of $76 million. This total includes a $41 million cash injection, led by Cathay Innovation with participation from prominent investors, including Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf. The funding will accelerate Bioptimus’s mission to build the world’s first universal AI foundation model for biology, aimed at revolutionizing research and innovation across the medical, biotech, cosmetic industries, and beyond.
By Bioptimus · Via Business Wire · January 14, 2025
Bioptimus Appoints Mathilda Strom as Founding Chief Operating Officer
Bioptimus, a leading AI company building the Foundation Model for biology, is thrilled to announce the appointment of Mathilda Strom as its Founding Chief Operating Officer. Mathilda joins Bioptimus with an extensive track record in building pioneering businesses and a reputation as a leader in scaling impactful organizations globally.
By Bioptimus · Via Business Wire · November 14, 2024
Bioptimus and Proscia Collaborate to Accelerate AI Innovation in Scientific Research and Drug Development for Improved Patient Care
Bioptimus, a French startup building the reference AI foundation model in biology, is excited to announce that its best-in-class H-optimus-0 foundation model is now integrated into Proscia’s Concentriq® Embeddings, enabling data scientists and researchers in pathology and life sciences to achieve breakthroughs in AI development at unprecedented speed and scale. This integration adds H-optimus-0 to the collection of foundation models that Concentriq Embeddings makes available on the Concentriq software platform where an enterprise’s data is stored, enriched, and analyzed from discovery to clinical trial.
By Bioptimus · Via Business Wire · October 23, 2024
Bioptimus Launches H-optimus-0, the World's Largest Open-Source AI Foundation Model for Pathology
Less than five months after its launch, French startup Bioptimus has announced the release of H-optimus-0, the world’s largest open-source AI foundation model for pathology. With 1.1 billion parameters, H-optimus-0 is trained on a proprietary dataset of several hundreds of millions of images extracted from over 500,000 histopathology slides across 4,000 clinical practices. This sets a new benchmark for state-of-the-art performance in several critical medical diagnostic tasks, from identifying cancerous cells to detecting genetic abnormalities in the tumor.
By Bioptimus · Via Business Wire · July 11, 2024
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
Today, French startup Bioptimus emerged from stealth following a seed funding round of $35M. Under the leadership of Professor Jean-Philippe Vert, PhD, Bioptimus unites a world-class team of scientists from Owkin and Google DeepMind alumni to transform ​biology with cutting-edge AI foundation model technologies that capture the various scales of biology. This funding round is led by Sofinnova Partners, with Bpifrance Large Venture, and additional support from global funds based in France, including Frst and multistage VC Cathay Innovation. Top global tech investors Headline, Hummingbird, NJF Capital, Owkin and Top Harvest Capital, as well as notable tech entrepreneur Xavier Niel, have joined the round to create a global leader in AI for biology in France.
By Bioptimus · Via Business Wire · February 20, 2024